Provident Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
14,780
+323
+2% +$26.1K 0.11% 50
2026
Q1
$1.25M Buy
14,457
+11,607
+407% +$1.11M 0.12% 44
2025
Q4
$274K Buy
+2,850
New +$277K 0.02% 78
2014
Q4
– Sell
-16,147
Closed -$1M – 55
2014
Q3
$1M Hold
16,147
– – 0.23% 28
2014
Q2
$1.03M Hold
16,147
– – 0.24% 29
2014
Q1
$994K Hold
16,147
– – 0.25% 29
2013
Q4
$927K Hold
16,147
– – 0.24% 31
2013
Q3
$860K Hold
16,147
– – 0.23% 29
2013
Q2
$831K Buy
+16,147
New +$798K 0.25% 29

Other funds holding MDT

Provident Investment Management's MDT Position: Q2 2026 in Review

Provident Investment Management increased its Medtronic (MDT) stake by 2.2% in Q2 2026, buying an estimated $26.1K and bringing the position to 14,780 shares worth $1.16M. The position accounts for 0.11% of the portfolio, ranked #50.

Provident Investment Management first reported a position in MDT in Q2 2013 and has held it in 9 quarters since. The position peaked at $1.25M in Q1 2026. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Provident Investment Management held 14,780 shares of Medtronic worth $1.16M as of Q2 2026.
  • Provident Investment Management bought 323 Medtronic shares in Q2 2026, an estimated $26.1K.
  • Medtronic made up 0.11% of Provident Investment Management's portfolio in Q2 2026, its #50 holding.
  • Provident Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 9 quarters since.
  • Provident Investment Management's Medtronic position peaked at $1.25M in Q1 2026.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Provident Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.